Jeffrey Hubbell (Cancer Biology, Immunology) is the Eugene Bell Professor in Tissue Engineering in the Pritzker School of Molecular Engineering. An international leader in bioengineering, Hubbell develops molecular and materials engineering approaches to advance immunotherapy.
His research is focused on vaccination in infectious disease, cancer and autoimmune disease. Hubbell designs materials that stimulate the immune system to fight infection or malignancy according to design, disabling certain aspects of the immune response to address auto-immune diseases such as multiple sclerosis or celiac disease. He coined the term “immuno-modulatory materials” to describe this newly emerging field of research. Along with his research associates, he holds more than 100 patents and has founded five companies.
Hubbell is the only UChicago faculty member to be elected to all three National Academies: the National Academy of Sciences, the National Academy of Engineering and the National Academy of Medicine. Hubbell also is a member of the National Academy of Inventors.
Three UChicago UChicago faculty members elected to National Academy of Sciences in 2023